Apokyn Bertek Pharmaceuticals - Treatment for Parkinson’s Disease
Apokyn (apomorphine hydrochloride injection) is the first and only
therapy in the United States for the acute, intermittent treatment
of hypomobility, “off” episodes (“end-of-dose
wearing off” and unpredictable “on/off” episodes)
associated with advanced Parkinson’s disease.
Posted: April 2004
Apokyn (apomorphine) FDA Approval History